Yuki Mizuno1,2、Thanakrit Suebboonprathueng3、Longxin Lin3、Ken-ichi Nishijima4、Yuji Kuge1,2 (1.Central Institute of Isotope Science, Hokkaido University, Sapporo, Japan、2.Global Center for Biomedical Science and Engineering, Hokkaido University, Sapporo, Japan、3.Graduate School of Biomedical Science and Engineering, Hokkaido University, Sapporo, Japan、4.Advanced Clinical Research Center, Fukushima Medical University, Fukushima, Japan)
Session information
[JSNM]Oral
Annual Scientific Meeting of the Japanese Society of Nuclear Medicine Program » 一般演題
Oral 03:Chemistry 3
Thu. Nov 7, 2024 10:40 AM - 11:40 AM Room 3 (5F 511+512, Conference Center, PACIFICO Yokohama)
座長:間賀田 泰寛(浜松医科大学 光医学総合研究所 分子病態イメージング分野)、籏野 健太郎(筑波大学医学医療系 応用分子イメージング学寄附研究部門)
Thanakrit Suebboonprathueng1、Yuki Mizuno2,3、Yuji Kuge2,3 (1.Graduate School of Biomedical Science and Engineering, Hokkaido University, Sapporo, Japan、2.Central Institute of Isotope Science, Hokkaido University, Sapporo, Japan、3.Global Center for Biomedical Science and Engineering, Hokkaido University, Sapporo, Japan)
Hiroki Kato1、Yuichiro Kadonaga1、Kazuhiro Ooe1、Xuhao Huang3、Hilmayanti Erina3、Atsushi Shimoyama3、Kazuya Kabayama1、Xiaojie Yin2、Hiromitsu Haba2、Atsushi Toyoshima1、Koichi Fukase2 (1.Department of Advanced Radioisotope Medicine, Institute for Radiation Sciences, The University of Osaka, Suita, Japan、2.Nishina Center for Accelerator-Based Science, RIKEN, Tokyo, Japan、3.Laboratory for natural product chemistry, Osaka University Graduate School of Science, Toyonaka, Osaka, Japan)
Hiroki Kato1、Hiroaki Shimamoto3、Yuichoro Kadonaga1、Kazuhiro Ooe1、Atsushi Shimoyama4、Kazuya Kabayama1、Xiaojie Yin2、Hiromitsu Haba2、Atsushi Toyoshima1、Koichi Fukase4 (1.Department of Advanced Radioisotope Medicine, Institute for Radiation Sciences, The University of Osaka, Suita, Japan、2.Nishina Center for Accelerator-Based Science, RIKEN, Tokyo, Japan、3.Osaka University, Graduate School of Dentistry, Suita, Japan、4.Laboratory for natural product chemistry, Osaka University Graduate School of Science, Toyonaka, Osaka, Japan)
Hiroaki Echigo1、Masayuki Munekane1、Takeshi Fuchigami1、Kenji Mishiro2、Eiichi Hinoi3、Hiroshi Wakabayashi4、Seigo Kinuya4、Kazuma Ogawa1,2 (1.Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan、2.Institute for Frontier Science Initiative, Kanazawa University, Kanazawa, Japan、3.Gifu Pharmaceutical University, Gifu, Japan、4.Department of Nuclear Medicine, School of Medicine, Kanazawa University, Kanazawa, Japan)
Shota Tsuchida1、Yoshihide Mizukoshi1、Hiroko Inaba1、Tatsuro Kotake1、Takanori Aoki1、Kai Orihara2、Yuichi Funase2、Kentaro Suzuki2、Takeru Ehara1、Satoshi Matsushima2、Masato Murakami1,2 (1.PeptiDream Inc., Kawasaki, Kanagawa, Japan、2.PDRadiopharma Inc., Sammu, Chiba, Japan)